Human Cardiac Progenitor Cells Engineered With Pim-I Kinase Enhance Myocardial Repair
Authors:
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R21HL102714, R01HL067245, R37HL091102, P01HL085577, RC1HL100891, R21HL102613, R21HL104544, RO1 HL113656, R01HL105759)
- National Institutes of Health (RC1HL100891, R01EB009689)
- Thoratec
This publication has 42 references indexed in Scilit:
- RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trialThe Lancet, 2011
- Effects of Age and Heart Failure on Human Cardiac Stem Cell FunctionThe American Journal of Pathology, 2011
- Adult Cardiac Stem Cells Are Multipotent and Support Myocardial RegenerationCell, 2003
- Intense myocyte formation from cardiac stem cells in human cardiac hypertrophyProceedings of the National Academy of Sciences, 2003
- Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted heartsNature Medicine, 2003
- Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2002
- Development of gene therapy for hematopoietic stem cells using lentiviral vectorsLeukemia, 2002
- Lentiviral Vectors for Gene Therapy of HIV-1 InfectionCurrent Gene Therapy, 2002
- Role of natural killer cells in allograft rejectionTransplantation Proceedings, 2000
- Synergistic Roles for Pim-1 and c-Myc in STAT3-Mediated Cell Cycle Progression and AntiapoptosisImmunity, 1999